Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulatory News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Improving radiation therapy dosing: FDA is holding a public meeting June 9 and 10 in Gaithersburg, Md., to discuss steps that makers of radiotherapy equipment - including linear accelerators, radiation therapy treatment planning systems and radiation therapy simulators - can take to reduce under- and overdosing and misaligned radiation exposures. FDA says it is rethinking pre-market approval requirements for such devices (1"The Gray Sheet" April 12, 2010). The first day of the workshop will focus on equipment features that should be incorporated into devices and software, and day two will focus on improving user training and quality assurance at medical facilities. FDA is accepting comments by May 15 in response to questions on device safeguards, facility reporting, training and quality assurance posted in a May 7 Federal Register 2notice. A related FDA initiative is addressing radiation overexposure in medical imaging procedures (3"The Gray Sheet" Feb. 15, 2010)

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028862

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel